- Report
- March 2025
- 71 Pages
Africa, Middle East
From €3202EUR$3,450USD£2,671GBP
- Report
- September 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,755GBP
- Report
- September 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,755GBP
- Report
- July 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,755GBP
- Report
- June 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,755GBP
- Report
- June 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,755GBP
- Report
- January 2024
- 140 Pages
Global
From €4177EUR$4,500USD£3,484GBP
- Report
- November 2023
- 86 Pages
Global
From €4177EUR$4,500USD£3,484GBP
- Report
- May 2022
- 190 Pages
Global
From €3249EUR$3,500USD£2,710GBP
- Report
- November 2025
- 85 Pages
Global
From €3500EUR$4,039USD£3,022GBP
- Report
- May 2023
- 74 Pages
Global
From €3500EUR$4,039USD£3,022GBP
- Report
- May 2023
- 92 Pages
Global
From €3500EUR$4,039USD£3,022GBP
From €120EUR$129USD£100GBP

The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions.
The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more